AI in Healthcare

Jun 27, 2026

Resumo do dia

Robot Talk Episode 162 – The robot doctor will see you now. How FDA Clearance of AI Opioid-Respiratory Monitoring Could Shape Danaher’s (DHR) Clinical Data Advantage. Stanford researchers will discuss their agentic 'scientists' that are on course to reshape drug discovery at VB Transform 2026

Principais notícias

1
Robot Talk Episode 162 – The robot doctor will see you now
Robot Talk Episode 162 – The robot doctor will see you now
2
How FDA Clearance of AI Opioid-Respiratory Monitoring Could Shape Danaher’s (DHR) Clinical Data Advantage
How FDA Clearance of AI Opioid-Respiratory Monitoring Could Shape Danaher’s (DHR) Clinical Data Advantage
3
Stanford researchers will discuss their agentic 'scientists' that are on course to reshape drug discovery at VB Transform 2026
Stanford researchers will discuss their agentic 'scientists' that are on course to reshape drug discovery at VB Transform 2026
4
Shared infrastructure, isolated tenants: Pool model multi-tenancy with Amazon Bedrock AgentCore
Shared infrastructure, isolated tenants: Pool model multi-tenancy with Amazon Bedrock AgentCore
5
Insilico Medicine, SK Biopharmaceuticals strike $2.5B AI drug discovery deal targeting neuroimmune therapies
Insilico Medicine, SK Biopharmaceuticals strike $2.5B AI drug discovery deal targeting neuroimmune therapies
6
Thermo Fisher Scientific Showcases New Capabilities Across Manufacturing, Clinical Development and AI-Enabled Research at BIO International 2026
Thermo Fisher Scientific Showcases New Capabilities Across Manufacturing, Clinical Development and AI-Enabled Research at BIO International 2026

Fontes

Share this with a friend

Send today's roundup to anyone who wants to keep up.

Get daily AI news free with AIToday

200+ AI sources, summarized in 1 minute. Email / LINE / Slack.

Robot Talk Episode 162 – The robot doctor will see you now

How FDA Clearance of AI Opioid-Respiratory Monitoring Could Shape Danaher’s (DHR) Clinical Data Advantage

Stanford researchers will discuss their agentic 'scientists' that are on course to reshape drug discovery at VB Transform 2026

Shared infrastructure, isolated tenants: Pool model multi-tenancy with Amazon Bedrock AgentCore

Insilico Medicine, SK Biopharmaceuticals strike $2.5B AI drug discovery deal targeting neuroimmune therapies

Thermo Fisher Scientific Showcases New Capabilities Across Manufacturing, Clinical Development and AI-Enabled Research at BIO International 2026